Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
570
-
Total 13F shares, excl. options
-
71,764,033
-
Shares change
-
-1,709,833
-
Total reported value, excl. options
-
$26,345,990,159
-
Value change
-
-$641,633,351
-
Put/Call ratio
-
91%
-
Number of buys
-
270
-
Number of sells
-
-232
-
Price
-
$367.09
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2016
673 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2016.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 570 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71,764,033 shares
of 104,986,330 outstanding shares and own 68.36% of the company stock.
Largest 10 shareholders include FMR LLC (7,824,326 shares), Capital World Investors (7,759,325 shares), WELLINGTON MANAGEMENT GROUP LLP (5,688,709 shares), VANGUARD GROUP INC (4,921,521 shares), STATE STREET CORP (3,240,549 shares), BlackRock Fund Advisors (2,447,609 shares), SANDS CAPITAL MANAGEMENT, LLC (2,302,802 shares), BlackRock Institutional Trust Company, N.A. (2,037,231 shares), JENNISON ASSOCIATES LLC (1,916,941 shares), and Artisan Partners Limited Partnership (1,891,598 shares).
This table shows the top 570 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.